Melissa D. Landis, Ph.D.
Affiliations: | 2006 | Case Western Reserve University, Cleveland Heights, OH, United States |
Area:
Molecular Biology, OncologyGoogle:
"Melissa Landis"Parents
Sign in to add mentor| Ruth A. Keri | grad student | 2006 | Case Western | |
| (Elucidating molecular mechanisms of ErbB2/Neu-induced mammary tumorigenesis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sahni JM, Gayle SS, Bonk KLW, et al. (2020) Correction: Bromodomain and extraterminal protein inhibition blocks growth of triple-negative breast cancers through the suppression of aurora kinases. The Journal of Biological Chemistry. 295: 9266 |
| Sahni JM, Gayle SS, Bonk KLW, et al. (2020) Correction: Bromodomain and extraterminal protein inhibition blocks growth of triple-negative breast cancers through the suppression of aurora kinases. The Journal of Biological Chemistry. 295: 9266 |
| Liu Y, Choi DS, Sheng J, et al. (2017) HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 Pathway. Stem Cell Reports |
| Sahni JM, Gayle SS, Weber-Bonk KL, et al. (2016) Bromodomain and extraterminal protein inhibition blocks growth of triple-negative breast cancers through the suppression of Aurora kinases. The Journal of Biological Chemistry |
| Balko JM, Schwarz LJ, Luo N, et al. (2016) Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence. Science Translational Medicine. 8: 334ra53 |
| Tanei T, Choi DS, Rodriguez AA, et al. (2016) Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells. Breast Cancer Research : Bcr. 18: 6 |
| Granados-Principal S, Liu Y, Guevara ML, et al. (2015) Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer. Breast Cancer Research : Bcr. 17: 25 |
| Ferrati S, Nicolov E, Bansal S, et al. (2015) Docetaxel/2-Hydroxypropyl β-Cyclodextrin Inclusion Complex Increases Docetaxel Solubility and Release from a Nanochannel Drug Delivery System. Current Drug Targets |
| Bharadwaj U, Eckols TK, Kolosov M, et al. (2015) Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer. Oncogene. 34: 1341-53 |
| Choi DS, Blanco E, Kim YS, et al. (2014) Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1. Stem Cells (Dayton, Ohio). 32: 2309-23 |